ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
FSHMD1A |
|
facioscapulohumeral muscular dystrophy 1A
|
|
|
0.638 |
0.808 |
COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
HSP90B2P |
Q58FF3
|
heat shock protein 90 beta family member 2, pseudogene
|
Chaperone
|
|
0.558 |
0.846 |
TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
MIR122 |
|
microRNA 122
|
|
|
0.468 |
0.808 |
MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
MIR130B |
|
microRNA 130b
|
|
|
0.547 |
0.808 |
MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
MIR145 |
|
microRNA 145
|
|
|
0.431 |
0.846 |
MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |